Does TRT actually cause blood pressure spikes? Here's what the data shows

What did @the.tudca.king actually say?

The creator argued that blood pressure spikes on TRT come down to exactly two causes: high estrogen driving water retention, or elevated hematocrit making blood too thick. He then said high hematocrit is the more likely culprit for most TRT users, dismissed estrogen-related water retention as rarely significant at TRT doses, and pivoted to promoting a product called HematFlow. His specific claim: the product can reduce systolic blood pressure by "20, 30 points" with most users seeing around 15 points of reduction, through a combination of hematocrit management, clotting effects, and a "natural ACE inhibitor."

That is a lot of therapeutic claims packed into a TikTok. Let's unpack what holds up.

Does the science back this up?

The hematocrit mechanism is real and well-documented. The estrogen dismissal is an oversimplification. The product claims are unsupported by published evidence.

Testosterone therapy does reliably raise hematocrit. A 2010 meta-analysis by Calof et al. in the Annals of Internal Medicine found polycythemia occurred significantly more often in testosterone-treated men than controls. Thicker blood increases viscosity, which raises peripheral vascular resistance, which raises blood pressure. That chain of events is physiologically coherent.

However, estrogen's role in fluid retention and blood pressure on TRT is not as negligible as the creator implies. Estradiol modulates the renin-angiotensin-aldosterone system, and supraphysiologic levels can drive sodium and water retention that meaningfully affects blood pressure in some individuals. A 2019 review by Handelsman in Endocrine Reviews notes that aromatization-related estrogen elevation is a real hemodynamic consideration, not a footnote.

As for HematFlow specifically, there is no peer-reviewed clinical trial data supporting a 20-30 point systolic reduction from this supplement. Citing anecdotes is not evidence.

What did they get wrong (or right)?

Credit where it is due: the two-mechanism framework is directionally correct. Hematocrit elevation is the more commonly discussed TRT-related cardiovascular concern in clinical literature, and the creator is right that it warrants monitoring. Mentioning clotting risk alongside blood viscosity is also appropriate.

But several things are wrong or at minimum unsupported. First, framing blood pressure spikes as caused by "only" two reasons is reductive. Sleep apnea worsened by testosterone, direct effects on vascular smooth muscle, and sympathetic nervous system activation are all documented contributors that he skips entirely. A 2021 paper by Corona et al. in Journal of Sexual Medicine reviews multiple hemodynamic pathways affected by TRT.

Second, the estrogen dismissal is too confident. It may be less common, but calling it unlikely for "most people on TRT doses" overstates the certainty.

Third, and most importantly, claiming a supplement produces "20, 30 points reduction in systolic values" without clinical trial data is a serious overreach. That magnitude of effect rivals prescription antihypertensives. Presenting it as routine for a product with no published efficacy trials is misleading, regardless of whether individual ingredients have some mechanism of action.

What should you actually know?

If your blood pressure is climbing on TRT, that is a clinical signal that needs a clinician's attention, not a supplement recommendation from a TikTok creator selling a product. Start with a full labs panel including hematocrit, hemoglobin, and estradiol. Hematocrit above 54 percent is a threshold many guidelines use to prompt dose adjustment or therapeutic phlebotomy.

The "natural ACE inhibitor" claim deserves scrutiny too. Some plant-derived compounds like peptides from fermented milk or certain flavonoids have shown modest ACE-inhibitory activity in small trials, but "natural ACE inhibitor" is not a standardized pharmacological category, and the effect sizes are nowhere near prescription ACE inhibitors like lisinopril.

If you genuinely need blood pressure management while on TRT, that conversation belongs with a prescribing physician who can evaluate whether your hematocrit needs addressing, whether your estrogen is contributing, whether your dose needs adjusting, or whether an actual antihypertensive medication is warranted. A supplement marketed by the person selling it is not a substitute for that evaluation.